Astrazeneca Pharma India has informed that it enclosed certificate dated December 3, 2024 issued by the RTA of the Company confirming the compliance of Regulation 74(5) of SEBI (DP) Regulations, 2018.
The above information is a part of company’s filings submitted to BSE.